Back to Search
TONYA BASS, PHARMD
PHARMD
Pharmacist
NPI: 1124392089Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
RPH-0010583(OR)
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
0010583(OR)
Research & Publications (20)
Optimization of dietary restriction protocols in Drosophila.
PMID 17921418·J Gerontol A Biol Sci Med Sci·2007
7-preclinical
Left main coronary artery: we are getting closer.
PMID 15065142·Catheter Cardiovasc Interv·2004
8-other
Overstretching undersized drug-eluting stents: a temporary solution.
PMID 15065138·Catheter Cardiovasc Interv·2004
8-other
Debulking does not benefit patients undergoing intracoronary beta-radiation therapy for in-stent restenosis: insights from the START trial.
PMID 12594697·Catheter Cardiovasc Interv·2003
3-trial
Effect of a standardised dietary restriction protocol on multiple laboratory strains of Drosophila melanogaster.
PMID 19119322·PLoS One·2009
7-preclinical
Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
PMID 19012950·Thromb Res·2009
8-other
Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis.
PMID 18829988·Diabetes·2009
8-other
Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial.
PMID 19455662·Catheter Cardiovasc Interv·2009
3-trial
Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.
PMID 19214963·Catheter Cardiovasc Interv·2009
8-other
Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
PMID 19089929·Catheter Cardiovasc Interv·2009
6-review
Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
PMID 18814218·Catheter Cardiovasc Interv·2008
4-observational
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study.
PMID 18567918·Eur Heart J·2008
2-rct
Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).
PMID 18549844·Am J Cardiol·2008
4-observational
Reduction of DILP2 in Drosophila triages a metabolic phenotype from lifespan revealing redundancy and compensation among DILPs.
PMID 19005568·PLoS One·2008
7-preclinical
Long-term outcomes in patients undergoing coronary stenting on dual oral antiplatelet treatment requiring oral anticoagulant therapy.
PMID 19064015·Am J Cardiol·2008
8-other
Prasugrel: a novel platelet ADP P2Y12 receptor antagonist. A review on its mechanism of action and clinical development.
PMID 18937620·Expert Opin Pharmacother·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 19200 SW MARTINAZZI AVE
TUALATIN, OR 97062 - Phone
- (503) 691-4233
Quick Facts
- NPI
- 1124392089
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile